Washington DC Sunrise

 

 

Recent Advocacy

  • AIPLA Comments on CNIPA Draft Measures for Prioritized Patent Examination

    April 1, 2026

    Arlington, VA. March 30, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments to the China National Intellectual Property Administration (CNIPA) regarding the Draft Measures for the Administration of Prioritized Examination of Patents.
  • AIPLA Files Amicus Brief in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc

    March 31, 2026

    Arlington, VA. March 27, 2026 – The American Intellectual Property Law Association (AIPLA) filed an amicus curiae brief with the Supreme Court in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., No. 24-889. AIPLA urges the Court to affirm the Federal Circuit’s application of the established Iqbal/Twombly pleading standard and inducement law in reviewing Hikma’s motion to dismiss Amarin’s claim that Hikma’s conduct, in combination with its “skinny label,” induced infringement of Amarin’s patented treatment methods.
  • Supreme Court Issues Unanimous Decision in Cox Communications, Inc. v. Sony Music Entertainment

    March 25, 2026

    On March 25, 2026, the Supreme Court issued a unanimous decision in Cox Communications, Inc. v. Sony Music Entertainment. The majority opinion limits contributory liability to situations where a party intended that its service be used for infringement, either by affirmatively inducing infringement or by selling a service tailored to infringement. A concurring opinion by Justice Sotomayor argues that the material contribution test should be retained, and that other forms of secondary liability can be found, which is consistent with the position asserted by AIPLA in its amicus brief filed on September 5, 2025. To read the opinion of the Court, please click here.